SHG:688621 - Beijing Sun-Novo Pharmaceutical Research Co Ltd

Beijing Sun Novo Pharmaceutica
Sector: Health Care, Industry: Pharmaceuticals

Add to Watchlist

•  Default
• New Watchlist

   

Yahoo Finance

• Summary
• Financials
• Dividend
• Prices
• Posts
• User
• Alerts

Balance Sheet Cash Flow Income Statement Key Ratios Personalized Adjust Display Metrics

Show %	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	Graph
Insider Holdings (%)	[friend]	[friend]	[friend]	[friend]	[friend]	-	-	-	-	0% -	51.55% -	43.69% -15.2%	41.73% -4.5%	43.62% 4.5%	43.62% 0%	43.62% 0%	48.6% 11.4%
Net Margin	[friend]	[friend]	[friend]	[friend]	[friend]	29.94% 39.7%	22.37% -25.3%	13.46% -39.8%	22.57% 67.7%	30.61% 35.6%	24.29% -20.6%	15.2% -37.4%	20.62% 35.7%	30.64% 48.6%	22.98% -25.0%	5.7% -75.2%	28.84% 406.2%
Gross Margin	[friend]	[friend]	[friend]	[friend]	[friend]	56.5% 3.6%	57.89% 2.5%	46.69% -19.3%	56.59% 21.2%	59.85% 5.8%	54.15% -9.5%	51.61% -4.7%	49.29% -4.5%	64.7% 31.3%	54.43% -15.9%	58.38% 7.3%	59.58% 2.1%
Operating Margin	[friend]	[friend]	[friend]	[friend]	[friend]	38.22% 30.3%	25.98% -32.0%	17.88% -31.2%	28.6% 59.9%	35.81% 25.2%	27.67% -22.7%	20.46% -26.1%	27.22% 33.1%	38.19% 40.3%	28.01% -26.7%	17.81% -36.4%	35.41% 98.8%
Total Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	128.34M 34.0%	116.98M -8.9%	152.55M 30.4%	147.96M -3.0%	176.35M 19.2%	170.93M -3.1%	181.37M 6.1%	232.43M 28.2%	228.61M -1.6%	230.96M 1.0%	240.12M 4.0%	252.26M 5.1%
Total Assets	[friend]	[friend]	[friend]	[friend]	[friend]	949.63M 125.3%	1.02B 7.0%	1.24B 22.3%	1.29B 3.6%	1.35B 4.6%	1.36B 1.1%	1.46B 7.5%	1.5B 2.4%	1.59B 6.3%	1.73B 8.5%	1.86B 7.8%	1.99B 6.6%
Total Liabilities	[friend]	[friend]	[friend]	[friend]	[friend]	229.22M 10.5%	268.6M 17.2%	473.01M 76.1%	482.34M 2.0%	510.83M 5.9%	481.67M -5.7%	555.1M 15.2%	542.44M -2.3%	613.1M 13.0%	687.48M 12.1%	805.76M 17.2%	979.51M 21.6%
Total Equity	[friend]	[friend]	[friend]	[friend]	[friend]	715.25M 241.2%	741.42M 3.7%	761.95M 2.8%	795.35M 4.4%	828.13M 4.1%	869.65M 5.0%	896.93M 3.1%	944.64M 5.3%	966.69M 2.3%	1.02B 5.5%	1.04B 2.0%	1.01B -2.5%
Operating CashFlow	[friend]	[friend]	[friend]	[friend]	[friend]	42.69M 646.2%	-	-	-	38.32M -	-	-	-	-41.82M -	-	-	-
Beginning Cash Position	[friend]	[friend]	[friend]	[friend]	[friend]	70.53M -35.5%	584.1M 728.1%	271.28M -53.6%	490.25M 80.7%	581.53M 18.6%	664.98M 14.4%	559M -15.9%	608.93M 8.9%	502.01M -17.6%	536.37M 6.8%	599.26M 11.7%	690.93M 15.3%
End Cash Position	[friend]	[friend]	[friend]	[friend]	[friend]	584.1M 728.1%	271.28M -53.6%	490.25M 80.7%	581.53M 18.6%	664.98M 14.4%	559M -15.9%	608.93M 8.9%	502.01M -17.6%	536.37M 6.8%	599.26M 11.7%	690.93M 15.3%	719.17M 4.1%
Free Cash Flow	[friend]	[friend]	[friend]	[friend]	[friend]	29.2M 3200.6%	-17.43M -	-9.36M -	-31.9M -	3.93M -	-54.05M -	82.11M -	-114.96M -	31.47M -	45.93M 45.9%	57.46M 25.1%	-12.64M -
Net Income (Cont Operations)	[friend]	[friend]	[friend]	[friend]	[friend]	60.31M 183.5%	-	-	-	87.06M -	-	-	-	119.31M -	-	-	-
Diluted Net Income	[friend]	[friend]	[friend]	[friend]	[friend]	-	-	-	-	-	-	-	-	-	-	-	-
Diluted EPS	[friend]	[friend]	[friend]	[friend]	[friend]	0.457 88.2%	0.314 -31.2%	0.064 -79.5%	0.3 366.7%	0.48 60%	0.37 -22.9%	0.25 -32.4%	0.43 72%	0.62 44.2%	0.48 -22.6%	0.12 -75%	0.65 441.7%
Return On Equity (%)	[friend]	[friend]	[friend]	[friend]	[friend]	8.31% -19.3%	3.59% -56.8%	2.73% -24.0%	4.29% 57.1%	6.65% 55.0%	4.89% -26.4%	3.12% -36.2%	5.21% 66.8%	7.33% 40.8%	5.34% -27.1%	1.33% -75.1%	7.08% 433.2%
Return On Assets (%)	[friend]	[friend]	[friend]	[friend]	[friend]	5.61% 15.6%	2.66% -52.5%	1.82% -31.7%	2.64% 45.3%	4.1% 55.3%	3.07% -25.2%	1.95% -36.4%	3.24% 65.9%	4.53% 40.0%	3.2% -29.5%	0.76% -76.2%	3.78% 396.2%